Bulletin
Investor Alert

New York Markets Close in:

Vir Biotechnology Inc.

NAS: VIR

GO
/marketstate/country/us

Market open

 --Real time quotes

May 11, 2021, 1:05 p.m.

VIR
/zigman2/quotes/214486077/composite

$

39.40

Change

+0.65 +1.68%

Volume

Volume 310,374

Real time quotes

/zigman2/quotes/214486077/composite

Previous close

$ 38.75

$ 39.40

Change

+0.65 +1.68%

Day low

Day high

$35.81

$40.00

Open

52 week low

52 week high

$25.31

$141.01

Open

Insider Actions for Vir Biotechnology Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/04/2021 Herbert W. Virgin
EVP, Research & CSO
1,375   Disposition at $46.03 per share. 63,291
05/04/2021 Herbert W. Virgin
EVP, Research & CSO
1,375   Derivative/Non-derivative trans. at $1.53 per share. 2,103
04/27/2021 Herbert W. Virgin
EVP, Research & CSO
7,900   Disposition at $49.5 per share. 391,050
04/27/2021 Herbert W. Virgin
EVP, Research & CSO
7,900   Derivative/Non-derivative trans. at $1.53 per share. 12,087
04/19/2021 Herbert W. Virgin
EVP, Research & CSO
2,340   Disposition at $48 per share. 112,320
04/19/2021 Herbert W. Virgin
EVP, Research & CSO
2,340   Derivative/Non-derivative trans. at $1.53 per share. 3,580
04/16/2021 Herbert W. Virgin
EVP, Research & CSO
3,500   Derivative/Non-derivative trans. at $1.53 per share. 5,355
04/13/2021 Herbert W. Virgin
EVP, Research & CSO
5,560   Disposition at $43.57 per share. 242,249
04/13/2021 Herbert W. Virgin
EVP, Research & CSO
5,560   Derivative/Non-derivative trans. at $1.53 per share. 8,506
04/09/2021 Herbert W. Virgin
EVP, Research & CSO
14,000   Derivative/Non-derivative trans. at $1.53 per share. 21,420
04/08/2021 ARCH Venture Partners LLC
5,989   0
04/08/2021 ARCH Venture Partners LLC
1,019   0
04/08/2021 ARCH Venture Partners LLC
3,161   0
04/08/2021 ARCH Venture Partners LLC
282,219   0
04/08/2021 ARCH Venture Partners LLC
217,781   0
04/08/2021 ARCH Venture Partners LLC
282,219   0
04/08/2021 ARCH Venture Partners LLC
217,781   0
04/07/2021 ARCH Venture Partners LLC
5,989   0
04/07/2021 ARCH Venture Partners LLC
1,019   0
04/07/2021 ARCH Venture Partners LLC
3,161   0
04/07/2021 ARCH Venture Partners LLC
282,219   0
04/07/2021 ARCH Venture Partners LLC
217,781   0
04/07/2021 ARCH Venture Partners LLC
282,219   0
04/07/2021 ARCH Venture Partners LLC
217,781   0
04/01/2021 ARCH Venture Partners LLC
1,016   0
04/01/2021 ARCH Venture Partners LLC
3,160   0
04/01/2021 Robert Taylor Nelsen
Director
5,987   0
04/01/2021 Jay Parrish
Chief Business Officer
2,315   Derivative/Non-derivative trans. at $1.58 per share. 3,657
04/01/2021 Jay Parrish
Chief Business Officer
4,629   Derivative/Non-derivative trans. at $1.48 per share. 6,850
04/01/2021 ARCH Venture Partners LLC
282,219   0
04/01/2021 ARCH Venture Partners LLC
217,781   0
04/01/2021 Jay Parrish
Chief Business Officer
6,944   Disposition at $51.4 per share. 356,921
03/30/2021 Robert Taylor Nelsen
Director
5,989   0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
32 Purchases
20 Sales
387,753
2,554,763
Last 6 months
49 Purchases
33 Sales
627,002
2,857,012
Last 12 months
100 Purchases
92 Sales
1,155,729
3,448,039

Officers and Executives

Dr. George A. Scangos
President, Chief Executive Officer & Director
Mr. Howard Horn
CFO, Secretary & Principal Accounting Officer
Dr. Michael E. Kamarck
Chief Technology Officer
Dr. Phil Pang
Chief Medical Officer
Dr. Herbert W. Virgin
Chief Scientific Officer & Executive VP-Research
Mr. Steven Rice
Chief Administrative Officer
Dr. Jay Parrish
Chief Business Officer
Dr. Antonio Lanzavecchia
Senior Vice President
Dr. Lynne Krummen
SVP-Regulatory Affairs & Program Leadership
Dr. David L. Gollaher
Head-Policy & Government Affairs
Ms. Irene Pleasure
Senior Vice President & General Counsel
Dr. Vicki L. Sato
Non-Executive Chairman
Mr. Dipchand V. Nishar
Independent Director
Ms. Sona Saira Ramasastry
Independent Director
Dr. Charles Elliott Sigal
Independent Director
Ms. Janet Ann Napolitano
Independent Director
Mr. Jeffrey S. Hatfield
Independent Director
Mr. Robert Taylor Nelsen
Independent Director
Mr. Robert J. Perez
Independent Director
Dr. Phillip A. Sharp
Independent Director
Mr. Robert J. More
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.